Sunday, January 18, 2026 | 01:44 AM ISTहिंदी में पढें
Senores Pharmaceuticals Ltd
Board Meeting Intimation for Considering And Approving The Un-Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025 And To Transact Other Business Matters
06:54 PM, 13th Jan 2026
Senores Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/01/2026 inter alia to consider and approve Un-audited Standalone and Consolidated Financial Results of the Company for the quarter and Nine Months ended December 31 2025 and to transact other business matters.